Cellectar Biosciences Inc (CLRB)
3.03
-0.01
(-0.33%)
USD |
NASDAQ |
Apr 19, 16:00
3.09
+0.06
(+1.98%)
After-Hours: 18:46
Cellectar Biosciences Cash and Short Term Investments (Quarterly): 9.565M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.565M |
| September 30, 2023 | 18.99M |
| June 30, 2023 | 5.153M |
| March 31, 2023 | 12.68M |
| December 31, 2022 | 19.87M |
| September 30, 2022 | 17.79M |
| June 30, 2022 | 24.81M |
| March 31, 2022 | 30.63M |
| December 31, 2021 | 35.70M |
| September 30, 2021 | 40.34M |
| June 30, 2021 | 46.78M |
| March 31, 2021 | 53.63M |
| December 31, 2020 | 57.17M |
| September 30, 2020 | 18.84M |
| June 30, 2020 | 22.45M |
| March 31, 2020 | 7.092M |
| December 31, 2019 | 10.61M |
| September 30, 2019 | 13.30M |
| June 30, 2019 | 16.85M |
| March 31, 2019 | 10.49M |
| December 31, 2018 | 13.26M |
| September 30, 2018 | 16.37M |
| June 30, 2018 | 4.181M |
| March 31, 2018 | 6.820M |
| December 31, 2017 | 10.01M |
| Date | Value |
|---|---|
| September 30, 2017 | 5.662M |
| June 30, 2017 | 8.313M |
| March 31, 2017 | 11.24M |
| December 31, 2016 | 11.44M |
| September 30, 2016 | 5.646M |
| June 30, 2016 | 7.922M |
| March 31, 2016 | 1.908M |
| December 31, 2015 | 3.858M |
| September 30, 2015 | 2.472M |
| June 30, 2015 | 4.833M |
| March 31, 2015 | 7.030M |
| December 31, 2014 | 9.423M |
| September 30, 2014 | 11.58M |
| June 30, 2014 | 1.626M |
| March 31, 2014 | 3.808M |
| December 31, 2013 | 2.418M |
| September 30, 2013 | 5.110M |
| June 30, 2013 | 5.828M |
| March 31, 2013 | 7.862M |
| December 31, 2012 | 4.678M |
| September 30, 2012 | 5.598M |
| June 30, 2012 | 7.146M |
| March 31, 2012 | 3.788M |
| December 31, 2011 | 5.506M |
| September 30, 2011 | 1.591M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
5.153M
Minimum
Jun 2023
57.17M
Maximum
Dec 2020
24.33M
Average
18.99M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 9.238M |
| Eli Lilly and Co | 2.928B |
| Actinium Pharmaceuticals Inc | 76.68M |
| Bristol-Myers Squibb Co | 12.28B |
| Altimmune Inc | 197.82M |